NYSE:AMRX - Amneal Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$8.29 +0.04 (+0.48 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$8.29
Today's Range$7.90 - $8.33
52-Week Range$7.90 - $24.48
Volume975,859 shs
Average Volume1.02 million shs
Market Capitalization$2.48 billion
P/E Ratio8.73
Dividend YieldN/A
Beta1.31

Headlines

Amneal Pharmaceuticals (NYSE AMRX) News Headlines

Source:
DateHeadline
Need To Know: Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Insiders Have Been Selling SharesNeed To Know: Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Insiders Have Been Selling Shares
finance.yahoo.com - May 24 at 3:59 PM
Amneal Pharmaceuticals (AMRX) Rating Increased to Strong-Buy at Raymond JamesAmneal Pharmaceuticals (AMRX) Rating Increased to Strong-Buy at Raymond James
www.americanbankingnews.com - May 21 at 7:37 AM
Amneal Pharmaceuticals Inc (AMRX) Receives Average Rating of "Hold" from AnalystsAmneal Pharmaceuticals Inc (AMRX) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 19 at 4:38 AM
 Analysts Anticipate Amneal Pharmaceuticals Inc (AMRX) Will Post Quarterly Sales of $467.21 Million Analysts Anticipate Amneal Pharmaceuticals Inc (AMRX) Will Post Quarterly Sales of $467.21 Million
www.americanbankingnews.com - May 19 at 1:14 AM
AMNEAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amneal Pharmaceuticals, Inc. - AMRXAMNEAL INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Amneal Pharmaceuticals, Inc. - AMRX
finance.yahoo.com - May 18 at 8:21 AM
Pradeep Bhadauria Buys 7,000 Shares of Amneal Pharmaceuticals Inc (AMRX) StockPradeep Bhadauria Buys 7,000 Shares of Amneal Pharmaceuticals Inc (AMRX) Stock
www.americanbankingnews.com - May 16 at 6:12 PM
Amneal Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare ConferenceAmneal Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 15 at 11:42 AM
AMNEAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The FirmAMNEAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Amneal Pharmaceuticals, Inc. To Contact The Firm
finance.yahoo.com - May 14 at 12:16 PM
Joseph Todisco Buys 15,000 Shares of Amneal Pharmaceuticals Inc (AMRX) StockJoseph Todisco Buys 15,000 Shares of Amneal Pharmaceuticals Inc (AMRX) Stock
www.americanbankingnews.com - May 13 at 8:37 PM
Andrew S. Boyer Acquires 19,000 Shares of Amneal Pharmaceuticals Inc (AMRX) StockAndrew S. Boyer Acquires 19,000 Shares of Amneal Pharmaceuticals Inc (AMRX) Stock
www.americanbankingnews.com - May 13 at 8:37 PM
Q2 2019 EPS Estimates for Amneal Pharmaceuticals Inc (AMRX) Reduced by Piper Jaffray CompaniesQ2 2019 EPS Estimates for Amneal Pharmaceuticals Inc (AMRX) Reduced by Piper Jaffray Companies
www.americanbankingnews.com - May 13 at 2:46 AM
Amneal Pharmaceuticals (AMRX) Releases Quarterly  Earnings Results, Misses Estimates By $0.07 EPSAmneal Pharmaceuticals (AMRX) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS
www.americanbankingnews.com - May 10 at 12:39 PM
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2019 Earnings Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 11:52 AM
BMO Capital Markets Lowers Amneal Pharmaceuticals (AMRX) Price Target to $13.00BMO Capital Markets Lowers Amneal Pharmaceuticals (AMRX) Price Target to $13.00
www.americanbankingnews.com - May 10 at 10:39 AM
Will Insiders Be Tempted To Buy More AMRX At The New 52-Week Low?Will Insiders Be Tempted To Buy More AMRX At The New 52-Week Low?
www.nasdaq.com - May 9 at 4:01 PM
Why Amneal Pharmaceuticals Stock Is Cratering TodayWhy Amneal Pharmaceuticals Stock Is Cratering Today
finance.yahoo.com - May 9 at 4:01 PM
Amneal Pharmaceuticals misses by $0.04, beats on revenueAmneal Pharmaceuticals misses by $0.04, beats on revenue
seekingalpha.com - May 9 at 11:50 AM
Amneal Pharma down 16% on Q1 resultsAmneal Pharma down 16% on Q1 results
seekingalpha.com - May 9 at 11:50 AM
Amneal Reports First Quarter 2019 Financial ResultsAmneal Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 9 at 11:50 AM
Amneal: 1Q Earnings SnapshotAmneal: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 11:50 AM
Amneal Pharmaceuticals (AMRX) Misses Q1 Earnings EstimatesAmneal Pharmaceuticals (AMRX) Misses Q1 Earnings Estimates
finance.yahoo.com - May 9 at 11:50 AM
Amneal Pharmaceuticals (AMRX) Releases FY 2019 Earnings GuidanceAmneal Pharmaceuticals (AMRX) Releases FY 2019 Earnings Guidance
www.americanbankingnews.com - May 9 at 10:21 AM
Amneal Pharmaceuticals (AMRX) Updates FY19 Earnings GuidanceAmneal Pharmaceuticals (AMRX) Updates FY19 Earnings Guidance
www.americanbankingnews.com - May 9 at 9:31 AM
Amneal Pharmaceuticals (AMRX) Scheduled to Post Earnings on ThursdayAmneal Pharmaceuticals (AMRX) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - May 2 at 1:31 AM
Here’s What Hedge Funds Think About Amneal Pharmaceuticals, Inc. (AMRX)Here’s What Hedge Funds Think About Amneal Pharmaceuticals, Inc. (AMRX)
finance.yahoo.com - April 25 at 3:56 PM
Amneal to Report First Quarter 2019 Results on May 9, 2019Amneal to Report First Quarter 2019 Results on May 9, 2019
finance.yahoo.com - April 8 at 8:57 AM
Amneal Names Pradeep Bhadauria as Chief Scientific OfficerAmneal Names Pradeep Bhadauria as Chief Scientific Officer
finance.yahoo.com - April 2 at 11:16 AM
Impax Labs pay-for-delay deal for generic Opana ER illegal - FTCImpax Labs pay-for-delay deal for generic Opana ER illegal - FTC
seekingalpha.com - April 1 at 1:13 PM
Amneal to sell Creo Pharma unitAmneal to sell Creo Pharma unit
seekingalpha.com - April 1 at 1:13 PM
Amneal Announces Agreement with Zentiva to Divest Creo PharmaAmneal Announces Agreement with Zentiva to Divest Creo Pharma
finance.yahoo.com - April 1 at 1:13 PM
Amneal Pharmaceuticals Inc (AMRX) President and CEO Robert A Stewart Bought $202,640 of SharesAmneal Pharmaceuticals Inc (AMRX) President and CEO Robert A Stewart Bought $202,640 of Shares
finance.yahoo.com - March 13 at 11:25 AM
Daily Biotech Pulse: Zafgen Wont File IND For Metabolic Disorder Drug, Positive Results For Akebias Anemia Drug - BenzingaDaily Biotech Pulse: Zafgen Won't File IND For Metabolic Disorder Drug, Positive Results For Akebia's Anemia Drug - Benzinga
www.benzinga.com - March 12 at 6:46 PM
Amneal Announces Launch of Rivastigmine Transdermal System - PRNewswireAmneal Announces Launch of Rivastigmine Transdermal System - PRNewswire
www.prnewswire.com - March 12 at 6:46 PM
Amneal Announces Launch of Rivastigmine Transdermal SystemAmneal Announces Launch of Rivastigmine Transdermal System
finance.yahoo.com - March 12 at 1:46 PM
Amneal Pharmaceuticals to Present at the Barclays Global Healthcare ConferenceAmneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 6 at 11:45 AM
Amneal Pharmaceuticals Q4 Earnings PreviewAmneal Pharmaceuticals Q4 Earnings Preview
seekingalpha.com - February 28 at 12:45 PM
Amneal Reports Fourth Quarter And Full Year 2018 Financial ResultsAmneal Reports Fourth Quarter And Full Year 2018 Financial Results
finance.yahoo.com - February 28 at 12:45 PM
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2018 Earnings Conference Call TranscriptAmneal Pharmaceuticals, Inc. (AMRX) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - February 28 at 12:45 PM
Amneal to Report Fourth Quarter and Full Year 2018 Results on February 28, 2019Amneal to Report Fourth Quarter and Full Year 2018 Results on February 28, 2019
finance.yahoo.com - January 24 at 11:54 AM
Does Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Have A Place In Your Portfolio?Does Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Have A Place In Your Portfolio?
finance.yahoo.com - January 22 at 3:47 PM
New CFO at Amneal PharmaceuticalsNew CFO at Amneal Pharmaceuticals
seekingalpha.com - January 22 at 11:10 AM
Amneal Names Accomplished Finance Executive Todd P. Branning As Chief Financial OfficerAmneal Names Accomplished Finance Executive Todd P. Branning As Chief Financial Officer
finance.yahoo.com - January 22 at 11:10 AM
Oversold Conditions For Amneal Pharmaceuticals (AMRX)Oversold Conditions For Amneal Pharmaceuticals (AMRX)
www.nasdaq.com - January 18 at 8:41 PM
FDA OKs Amneals generic Exelon PatchFDA OKs Amneal's generic Exelon Patch
seekingalpha.com - January 14 at 8:29 AM
Amneal Announces Approval of Rivastigmine Transdermal SystemAmneal Announces Approval of Rivastigmine Transdermal System
finance.yahoo.com - January 14 at 8:29 AM
Amneal Pharmaceuticals Inc.Amneal Pharmaceuticals Inc.
www.barrons.com - January 9 at 3:40 PM
Amneal Pharmaceuticals (AMRX) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowAmneal Pharmaceuticals (AMRX) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 8 at 3:47 PM
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate SecretaryAmneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
finance.yahoo.com - January 4 at 9:28 AM
Amneal Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare ConferenceAmneal Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 19 at 11:16 AM
Tracking Ole Andreas Halvorsens Viking Global Portfolio - Q3 2018 UpdateTracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2018 Update
seekingalpha.com - November 26 at 10:28 AM
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel